What Can Feminists Make of the Eugenicist History of Abortion?
By Erika Rodriguez,
Minnesota Women's Press
| 05. 24. 2023
In a footnote to the Dobbs v. Jackson decision that overturned Roe v. Wade last summer, Samuel Alito referenced an old right-wing talking point tying abortion advocacy to eugenics. He suggested that some pro-choice advocates were “motivated by a desire to suppress the size of the African American population,” and in dong so echoed Clarence Thomas’s 2019 concurrence in Box v. Planned Parenthood, which stated that abortion restrictions prevent “abortion from becoming a tool of modern-day eugenics.”
In the wake of the Dobbs ruling, many advocates denied the historical ties between abortion and eugenics. Yet the inconvenient fact remains that early 20th-century abortion rights were frequently articulated in relation to eugenic standards of “unfitness” and “racial betterment” in ways that remain relevant today. Although we may most frequently encounter this history through bad-faith arguments aimed at stripping away reproductive rights, feminists have a responsibility to grapple seriously with the ties between disability, abortion, and eugenics.
Pro-choice advocates have argued that the early abortion movement was directly opposed to eugenic practices (such as forced breeding or sterilization) because its focus was...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...